p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling

Proceedings of the National Academy of Sciences of the United States of America
Douglas J ShefflerB L Roth

Abstract

G protein-coupled receptors (GPCRs) are essential for normal central CNS function and represent the proximal site(s) of action for most neurotransmitters and many therapeutic drugs, including typical and atypical antipsychotic drugs. Similarly, protein kinases mediate many of the downstream actions for both ionotropic and metabotropic receptors. We report here that genetic deletion of p90 ribosomal S6 kinase 2 (RSK2) potentiates GPCR signaling. Initial studies of 5-hydroxytryptamine (5-HT)(2A) receptor signaling in fibroblasts obtained from RSK2 wild-type (+/+) and knockout (-/-) mice showed that 5-HT(2A) receptor-mediated phosphoinositide hydrolysis and both basal and 5-HT-stimulated extracellular signal-regulated kinase 1/2 phosphorylation are augmented in RSK2 knockout fibroblasts. Endogenous signaling by other GPCRs, including P2Y-purinergic, PAR-1-thrombinergic, beta1-adrenergic, and bradykinin-B receptors, was also potentiated in RSK2-deficient fibroblasts. Importantly, reintroduction of RSK2 into RSK2-/- fibroblasts normalized signaling, thus demonstrating that RSK2 apparently modulates GPCR signaling by exerting a "tonic brake" on GPCR signal transduction. Our results imply the existence of a novel pathway regulating GP...Continue Reading

References

Nov 22, 1996·The Journal of Biological Chemistry·Y ZhaoD E Moller
Dec 24, 1997·Journal of Neuroscience Methods·J R Backstrom, E Sanders-Bush
Mar 27, 1999·The Journal of Biological Chemistry·C ChinniE J Mackie
Jul 20, 1999·Molecular and Cellular Endocrinology·M Frödin, S Gammeltoft
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·J C BruningD Muller-Wieland
Jun 22, 2000·Nature Neuroscience·H HusiS G Grant
Aug 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bryan L RothRichard B Rothman
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Kristen L PierceRobert J Lefkowitz
Sep 5, 2002·American Journal of Medical Genetics·Alasdair G W Hunter
Oct 4, 2002·Journal of Medical Genetics·A Hanauer, I D Young
Oct 1, 2003·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Kwok-Kuen CheungGeoffrey Burnstock
Oct 14, 2003·Bone·Charles N PagelEleanor J Mackie
Apr 3, 2004·Nature Reviews. Drug Discovery·Bryan L RothWesley K Kroeze
Jul 21, 2004·Molecular Psychiatry·P J Harrison, D R Weinberger
Sep 17, 2004·Molecular Pharmacology·Susan F Steinberg
Oct 7, 2004·Pharmacology & Therapeutics·Joël BockaertPhilippe Marin
Nov 20, 2004·Science·Gwendolyn F ElphickWalter J Atwood
Dec 14, 2004·The Journal of Biological Chemistry·Blaine N Armbruster, Bryan L Roth
Apr 23, 2005·Science·Robert J Lefkowitz, Sudha K Shenoy
Oct 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gareth M ThomasRichard L Huganir

❮ Previous
Next ❯

Citations

Apr 24, 2009·Molecular and Cellular Biochemistry·Mathieu BoissanMarie-Lise Lacombe
Sep 12, 2008·Biological Reviews of the Cambridge Philosophical Society·Bernard Crespi
Jun 25, 2010·American Journal of Physiology. Cell Physiology·Geneviève LarocheDavid P Siderovski
Feb 11, 2016·Cell Communication and Signaling : CCS·Anne HennigIgnacio Rubio
Feb 5, 2016·Pharmacological Reviews·David E Nichols
Sep 11, 2010·European Journal of Pharmacology·J Adolfo García-SáinzLuz del Carmen Medina
Oct 27, 2015·Frontiers in Pharmacology·Gongliang Zhang, Robert W Stackman
Jan 23, 2009·Developmental Neurobiology·Matthias FischerMichael Sendtner
Jul 25, 2007·Journal of Neurochemistry·Hanoch KaphzanKobi Rosenblum
Aug 16, 2011·Journal of Neurochemistry·Anne SchneiderAndré Hanauer
Sep 22, 2012·British Journal of Pharmacology·Terry Kenakin
Oct 5, 2012·Molecular Pharmacology·Ishier RaoteMitradas M Panicker
Jun 7, 2017·Behavior Genetics·Matthias FischerAngelika G Schmitt-Böhrer
Jun 8, 2018·Frontiers in Behavioral Neuroscience·Matthias Fischer, Thomas Raabe
Jun 30, 2019·Pharmacogenomics·Rabha M YounisJoseph L McClay
Dec 15, 2010·The Journal of Biological Chemistry·Friederike CuelloMetin Avkiran
Nov 20, 2021·Journal of Neurochemistry·Samuel T SlocumBryan L Roth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.